🇺🇸 FDA
Patent

US 11903945

Methods of treating antipsychotic-induced weight gain with miricorilant

granted A61KA61K31/513A61K31/551

Quick answer

US patent 11903945 (Methods of treating antipsychotic-induced weight gain with miricorilant) held by Corcept Therapeutics Incorporated expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/513, A61K31/551, A61P, A61P3/04